MannKind | MNKD - Stock


MannKind reported $44.42M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Adma Biologics USD 239.31M 17.22M Jun/2026
BioCryst Pharmaceuticals USD 6.06M 71K Jun/2026
Eli Lilly USD 16.79B 2.26B Jun/2026
Halozyme Therapeutics USD 137.14M 18.33M Jun/2026
Insmed USD 142.38M 9.48M Jun/2026
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
MacroGenics USD 9.5M 1.59M Mar/2026
MannKind USD 44.42M 4.75M Jun/2026
Merck USD 6.21B 272M Jun/2026
Novavax USD 10.01M 1.45M Jun/2026
Novo Nordisk DKK 51.35B 8.5B Mar/2026
Pfizer USD 9.94B 722M Jun/2026
Sanofi EUR 24.12B 620M Jun/2026